Tumors, from Aifa ok to reimbursement of drug for light chain amyloidosis
Daratumumab, the first fully human anti-Cd 38 monoclonal antibody approved for the treatment of multiple myeloma ...
Read moreDaratumumab, the first fully human anti-Cd 38 monoclonal antibody approved for the treatment of multiple myeloma ...
Read moreAbbVie announces that the Italian drug agency Aifa has approved the reimbursement in Italy of Rinvoq* ...
Read moreAbbVie announces that the Italian drug agency Aifa has approved the reimbursement in Italy of Skyrizi* ...
Read more© Ruetir 2023. All Rights Reserved.